(VIANEWS) – Shares of Xenetic Biosciences (NASDAQ Composite: XBIO) slid 5.16% to $2.39 at 15:20 EST on Tuesday, after five successive sessions in a row of losses. NASDAQ Composite is sliding 0.42% to $15,042.44, after four consecutive sessions in a row of losses. This seems, up to now, a somewhat negative trend trading session today.
Xenetic Biosciences’s last close was $2.71, 53.68% below its 52-week high of $5.85.
Today’s last reported volume for Xenetic Biosciences is 296075 which is 97.08% below its average volume of 10160853.
Xenetic Biosciences’s Sales
Xenetic Biosciences’s sales growth is 72.4% for the ongoing quarter and a decline by 33.8% for the next. The company’s growth estimates for the ongoing quarter and the next is 90% and 6.3%, respectively.
Xenetic Biosciences’s Revenue
Year-on-year quarterly revenue growth grew by 786.7%, now sitting on 436.94k for the twelve trailing months.
Xenetic Biosciences’s Stock Yearly Top and Bottom Value
Xenetic Biosciences’s stock is valued at $2.39 at 15:20 EST, way under its 52-week high of $5.85 and way higher than its 52-week low of $0.76.
Xenetic Biosciences’s Moving Average
Xenetic Biosciences’s worth is way below its 50-day moving average of $3.27 and above its 200-day moving average of $2.39.
More news about Xenetic Biosciences (XBIO).